PartnershipUpdated on 13 August 2025
Early detection of kidney injury
About
The solution is used in conjunction with common urine glucose measurement kits to determine trehalase activity, a key marker of kidney function. By analyzing this specific enzyme, Argeron Nephrotest helps healthcare professionals identify potential acute kidney injury at an early stage. This is particularly useful for hospitalized and intensive care patients, where early detection can lead to timely intervention and improved outcomes.
Looking for
- Research and Development
- Technology Transfer
- Technology Trials / Testing
Organisation
Argeron Medikal Araştırma Sanayi ve Ticaret A.Ş.
Antalya, Türkiye
Similar opportunities
Project cooperation
Looking for Clinical trial of early diagnosis of kidney damage in patients
- Research
- Execution
- Biotechnology
Bülent BIDI
CEO at Argeron Medikal Araştırma Sanayi ve Ticaret A.Ş.
Antalya, Türkiye
Expertise
Advanced Medical and Biotechnology Solutions Medical Research and Diagnostic Development
- Healthcare
- Biotech, Pharma and Cosmetics
- Food, Beverages and Agriculture
Bülent BIDI
CEO at Argeron Medikal Araştırma Sanayi ve Ticaret A.Ş.
Antalya, Türkiye
Partnership
Argeron Magnetic Auto Injector
- Technology Transfer
Bülent BIDI
CEO at Argeron Medikal Araştırma Sanayi ve Ticaret A.Ş.
Antalya, Türkiye